Best For
Evidence reviews of peptides discussed in specific health and performance contexts — injury repair, recovery, cognitive enhancement, and more. These are evidence reviews, not recommendations.
An evidence review of peptides discussed for cognitive enhancement — Cerebrolysin, Noopept, Semax, and Dihexa — ranked by depth of clinical evidence and regulatory status. Cerebrolysin and Semax are Russian pharmaceuticals with some clinical data, Noopept has published Russian human trials, and Dihexa remains preclinical-only.
What the public source record shows about peptides studied for growth hormone release — tesamorelin, sermorelin, MK-677, CJC-1295, and ipamorelin ranked by evidence depth and regulatory status.
What the public source record shows about peptides studied for immune support — Thymosin Alpha-1, LL-37, and KPV ranked by depth of clinical evidence and regulatory status.
An evidence review of peptides discussed in injury repair and tissue healing contexts — including BPC-157 and TB-500 — with evidence levels, regulatory status, and internal links to compound pages. This is an evidence review, not a recommendation.
An evidence review of peptides discussed in muscle recovery contexts — including BPC-157, TB-500, and related compounds — with evidence levels, regulatory status, and internal links to compound pages. This is an evidence review, not a recommendation.
Source-backed guide to the most researched peptides for skin repair, wrinkle reduction, and anti-aging biology — GHK-Cu, Argireline, Matrixyl, and Epitalon.
What the public source record shows about peptides discussed for sleep — DSIP and Epitalon reviewed by evidence depth and regulatory status. Both are investigational research peptides with limited human clinical evidence and no FDA approval for sleep indications.
What the public source record shows about peptides studied for weight loss — retatrutide, tirzepatide, and semaglutide ranked by evidence depth and regulatory status.